Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia
摘要
Premature infants with bronchopulmonary dysplasia (BPD) are at risk for pulmonary hypertension (PH). We sought to evaluate outcomes of a PH screening protocol.
Study designSingle-center retrospective cohort study of premature infants with ≥moderate BPD from 6/2017 to 11/2022 subject to an institutional PH screening protocol that included echocardiogram and serum N-terminal pro B-type natriuretic peptide (NT-proBNP) levels measured at 36 weeks postmenstrual age.
ResultScreening echocardiography detected PH in 15% (95% CI 10.0%, 22.1%). Multivariate analysis identified an association between lower gestational age and incidence of PH. There was no difference in right ventricular systolic function metrics among infants with PH compared to those without. Sensitivity and specificity of serum NT-proBNP were 57% and 45%, respectively.
ConclusionEchocardiographic screening can detect unrecognized PH in infants before significant decrement of right ventricular performance, while serum NT-proBNP may not be a reliable screening tool for PH in infants with BPD.